MedicarePartD.guide

A non-government resource built from CMS public data

Multiple sclerosis drugs on every 2026 North Carolina Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in North Carolina cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

12 plans, cheapest premium first. Scroll sideways for all of them →

Multiple sclerosis drugs by 2026 North Carolina Part D plan
DrugWellcare Value Script$3.60/moS4802-143Wellcare Classic$4.70/moS4802-081Humana Basic Rx Plan$6.80/moS5884-133Humana Value Rx Plan$32.00/moS5884-187AARP Medicare Rx Saver from UHC$56.90/moS5921-353HealthSpring Extra Rx$78.00/moS5617-358Blue Medicare Rx Standard$83.90/moS5540-002SilverScript Choice$90.20/moS5601-016HealthSpring Assurance Rx$110.40/moS5617-217Humana Premier Rx Plan$110.90/moS5884-154AARP Medicare Rx Preferred from UHC$119.80/moS5921-390Blue Medicare Rx Enhanced$163.20/moS5540-004
KesimptaofatumumabNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA25%QL 1.6/28dNot coveredTier 5PA25%QL 1.6/28dNot coveredNot coveredTier 5PA33%QL 1.6/28d
teriflunomidegeneric AubagioTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 4PA32%QL 30/30dTier 4PA34%QL 30/30dNot coveredNot coveredNot coveredTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 4PA50%QL 30/30dTier 433%QL 30/30dNot covered
dimethyl fumarategeneric TecfideraTier 4PA40%QL 56/28dTier 4PA27%QL 56/28dNot coveredNot coveredTier 434%QL 56/28dTier 4PA31%QL 14/30dTier 4PA32%QL 60/30dNot coveredTier 4PA32%QL 14/30dTier 4PA50%QL 14/30dTier 433%QL 56/28dTier 4PA40%QL 60/30d
Vumeritydiroximel fumarateNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 5PA33%QL 120/30d
fingolimodgeneric GilenyaTier 5PA25%QL 30/30dTier 5PA25%QL 30/30dTier 3PA25%QL 30/30dTier 3PA20%QL 30/30dTier 434%QL 30/30dNot coveredNot coveredTier 5PA25%QL 30/30dNot coveredTier 3PA$45.00QL 30/30dTier 433%QL 30/30dTier 4PA40%QL 30/30d
MayzentsiponimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
ZeposiaozanimodNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
MavencladcladribineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.